Phosphate levels are associated with a slew of cardiovascular and renal complications, with
hyperphosphatemia serving as a direct stimulus to vascular calcification in CKD patients. As phosphate
begins to build up, our mineral homeostasis goes off course – resulting in capillaries being clogged
and our bones breaking down. Currently, there is no point-of-care method for phosphate detection, with
blood analysis being the main clinical diagnostic tool. Other biomarker abnormalities like elevated
potassium, FGF23, and PTH are also associated with CKD. A weak kidney may lead to other problems like
vascular calcification and bone abnormalities – resulting in serious illness and eventually death.
After speaking with nephrologists, many CKD patients are diabetic, so glucose is also a valuable
biomarker to detect for patient car